How It Works



News

Click on the links below for News and Publications

ClinicalStudyDataRequest.com Announces Partnerships with Global Academic Research Funders to Expand Researchers’ Access to Patient-level Clinical Trial Data

BOSTON – April 23, 2018 – ClinicalStudyDataRequest.com (CSDR), the first-in-class online resource giving researchers access to patient-level clinical trial data from 14 of the world’s leading pharmaceutical companies across multiple therapeutic areas, today announced new strategic collaborations with four major non-profit partners: The Bill & Melinda Gates Foundation, Cancer Research UK, Medical Research Council and Wellcome Trust. The new consortium partners expand CSDR’s ability to deliver upon its promise to help accelerate life-saving discoveries and efficiently translate big data into smart data that generates valuable research results.

"Making clinical trial data available to biomedical researchers across all geographies will help improve academic and clinical research activities, the drug development process, and ultimately, enhance patients’ health outcomes," said Scott Martin, Chair of the CSDR Steering Committee. "CSDR is pleased to join forces with such outstanding research collaborators who share our vision of safeguarding privacy while enabling transparency around the vast amounts of valuable data borne from clinical trials."

Since its founding in 2013 CSDR has demonstrated steady growth both in the number of pharmaceutical partners making their data available to the research community as well as the number of researcher proposals submitted through the organization’s one-stop shop for accessing de-identified patient data from the more than 3,500 studies worldwide. With 57 researchers who accessed data through CSDR having already published or pending publication of journal articles on their findings, the organization recently launched a redesign of its website to allow for an improved, more efficient user experience. With the addition of non-profit partners, CSDR is uniquely positioned to not only serve the research community through unparalleled access to patient-level clinical data from the pharmaceutical industry, but also as a resource through which academic-led clinical trial data now can be shared..

“Data is one of the biggest outputs of the research that Wellcome Trust supports, and we support CSDR’s goal of ensuring that it is shared in a way that is independent, transparent, and equitable to reduce the barriers of data re-use,” said Jennifer O’Callaghan, Clinical Data Sharing Manager with Wellcome Trust. “CSDR addresses the needs of the academics whom we fund by providing them with a single, innovative solution for accessing and analyzing data from multiple trials as a means of saving time and effort – altogether maximizing the value of the research that we fund and creating an opportunity to make academic clinical trial data more discoverable, accessible and reusable for optimal impact and value. We strongly encourage our researchers to use CSDR for sharing and accessing trial data.”

As clinical trial data sharing continues to expand, both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have put into place basic requirements to support clinical trial transparency and data disclosure, but are still calling for improvements around the scope, clarity, consistency, and usability of disclosed data. Through its innovative and functional approach to data sharing and scientific exchange, CSDR is answering that call with an unprecedented mechanism for ensuring privacy of trial subjects in tandem with expedited advancement of scientific discoveries and innovations.

About ClinicalStudyDataRequest.com
ClinicalStudyDataRequest.com is the industry leader in global clinical trial data transparency. Its multi-Sponsor Request System provides a secure process for Researchers to request access to global clinical trial data through a publicly available website. An Independent Review Panel review data requests received from external researchers. Wellcome Trust provides secretariat support to this panel and oversees the review process. Access to clinical trial data provides opportunities to conduct further research that can help advance medical science and improve patient care. This helps ensure the data provided by research participants are used to maximum effect in the creation of knowledge and understanding.

Media Inquiries
Debbie Field
T: (512) 590-2097
E: dfield@spectrumscience.com

ClinicalStudyDataRequest.com Expansion Enables Researchers to Now Access Patient-Level Data in More than 3,000 Clinical Trials

BOSTON—December 15, 2016—ClinicalStudyDataRequest.com (CSDR) a cross-industry initiative providing Researchers with access to clinical trial data from 13 major pharmaceutical companies, including trials that involve multiple Sponsors, has significantly increased the number of trials available to more than 3,200.

CSDR offers medical and scientific Researchers an unparalleled array of clinical trial data that can facilitate collaboration, advance scientific knowledge, and potentially improve outcomes for patients. Through this portal, Researchers can request anonymized patient-level data from a list of more than 3,200 clinical trials via an independently reviewed process managed by the Wellcome Trust.

The available trials span all major disease areas. For example, there are more than 300 diabetes trials listed. Since the initiative was launched, there have been more than 250 requests from Researchers for trial data. Study Sponsors interested in listing studies on the site may contact CSDR here.

"ClinicalStudyDataRequest.com and its member companies are proud to have reached these important milestones of more than 3,200 trials listed and 250 requests made. This consortium continues to raise the goal and Sponsors are working together and with others to continually seek new ways to increase the number of trials listed and take steps to facilitate easier request and data-access mechanisms," said Scott Martin, chair of the ClinicalStudyDataRequest.com Steering Committee.

About ClinicalStudyDataRequest.com

ClinicalStudyDataRequest.com is the industry leader in global clinical trial data transparency. Its multi-Sponsor Request System provides a secure process for Researchers to request access to global clinical trial data through a publicly available website. An Independent Review Panel and process overseen by the Wellcome Trust review data requests received from external Researchers. Access to clinical trial data provides opportunities to conduct further research that can help advance medical science and improve patient care. This helps ensure the data provided by research participants are used to maximum effect in the creation of knowledge and understanding.

About ideaPoint

ClinicalStudyDataRequest.com is built on a unique platform called ideaPoint, which is dedicated to providing clients with software solutions that help them repeatedly spot and seize the innovation and partnering opportunities that create growth through new products, new services and new business models. Since its launch in 2008, ideaPoint software has been used to transform and solidify innovation and strategic growth programs across global companies in science-based industries. For additional information, please visit www.idea-point.com

Media Contact:
Scott Martin
KMR Group
312.795.0400
Email: smartin@kmrgroup.com
ideaPoint Appoints Scott Martin as Independent Chair of ClinicalStudyDataRequest.com

Appointment Furthers the Development and Promotion of Responsible Clinical Trial Data Sharing to enhance Research and Improve Patient Care

BOSTON (September 26, 2016) -ideaPoint, an Anaqua company providing software to transform and solidify innovation and strategic growth programs across global companies in science-based industries, today announced the appointment of Scott Martin as independent chair of the steering committee for ClinicalStudyDataRequest.com (CSDR).

Designed for use by the life sciences research community, CSDR is a secure web-based solution that provides a mechanism to request access to global clinical study data and supporting documents from multiple companies for the purpose of analyzing the data to advance scientific and medical research and improve patient care. Martin will provide Sponsor-independent leadership and support the consortium's strategic vision to enhance Sponsor collaboration and researcher access. Martin has held the position of principal at the Chicago-based KMR Group for 20 years and has been active in many leading R&D organizations within the biopharmaceutical industry, including the Pharmaceutical Benchmarking Forum (PBF) which was founded in 1997.

CSDR was established in 2013 and built on the ideaPoint platform, to provide Researchers and data Sponsors with a secure system to manage the request process of research data for the benefit of world health. Sponsor members include Astellas, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Eisai, GSK, Lilly, Novartis, Roche, Sanofi, Takeda, UCB and ViiV Healthcare.

"CSDR is poised to provide even greater benefits to the broader healthcare community, expanding access to clinical data that in turn can prove crucial to Researchers trying to cure disease," said Scott Martin, Chair of ClinicalStudyDataRequest.com Steering Committee. "I am pleased to be able to help CSDR promote greater openness and access to data."

"ideaPoint and the Sponsors believe this is an important next step for CSDR," said Scott Shaunessy, CEO, ideaPoint. "Scott Martin has been successfully chairing the well-established Pharma Benchmarking Forum, a multi-Sponsor forum that parallels the CSDR steering committee in many ways. Scott has excellent knowledge of clinical development, the pharma business, and academic research. He is a skilled moderator and facilitator and we believe he will be instrumental as we work together to foster further growth and success".

About ClinicalStudyDataRequest.com

ClinicalStudyDataRequest.com is the industry leader in global clinical trial data transparency. It is multi-Sponsor Request System which provides a secure process for Researchers to request access to global clinical trial data through a publically available website. An Independent Review Panel and process overseen by the Wellcome Trust review Data requests received from external Researchers. Access to clinical trial data provides opportunities to conduct further research that can help advance medical science and improve patient care. This helps ensure the data provided by research participants are used to maximum effect in the creation of knowledge and understanding. Sponsors/Funders who have committed to use this site are Astellas, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Eisai, GSK, Lilly, Novartis, Roche, Sanofi, Takeda, UCB and ViiV Healthcare.

If you are a study Sponsor interested in listing studies on this site, contact information is provided here.

About Anaqua, Inc.

Anaqua helps corporations and law firms turn intellectual property into competitive advantage. Its software platform combines insight from big data analytics with critical tools, best practice workflows and services into one efficient, intelligent environment that helps IP practices work more efficiently and make better decisions faster. Many of the best-known brands and most innovative products were conceptualized, evaluated, protected and monetized through the ANAQUA platform. Founded in 2004 by IP leaders from The Coca-Cola Company, Ford Motor Company, Kimberly-Clark and British American Tobacco, Anaqua is a privately held company headquartered in Boston (U.S.) and has locations across Europe and Asia.

For additional information, please visit http://www.anaqua.com.

About ideaPoint

ideaPoint, an Anaqua product, is dedicated to providing clients with software solutions that help them repeatedly spot and seize the innovation and partnering opportunities that create growth through new products, new services and new business models.

Since its launch in 2008, ideaPoint has delivered the software to transform and solidify innovation and strategic growth programs across global companies in science-based industries.

For additional information, please visit www.idea-point.com

Media Contact:
Scott Martin
KMR Group
312.795.0400
Email: smartin@kmrgroup.com
ideaPoint, Inc. Announces Launch of Portal Providing Researchers Opportunity to Request Access to Clinical Data from Five Global Pharmaceutical Companies

Initiative designed to facilitate transparent data sharing in support of advancing biomedical research

Quincy, MA - January 2, 2014 - ideaPoint, Inc., a leading provider of partnering and collaboration systems for global enterprises, today announced the availability of a new portal providing a secure request system for research-focused clinical trial data (https://clinicalstudydatarequest.com). Site Sponsors currently include Boehringer Ingelheim, GlaxoSmithKline, Roche, Sanofi and ViiV Healthcare.

With extensive experience providing online collaboration solutions for global pharmaceutical companies, ideaPoint powers the technology behind the new site's secure request and evaluation process.

"The design and development of this user-friendly site is an outgrowth of our collaboration and partnering software. Supporting this global consortium was a natural expansion of our work with pharmaceutical company clients, and we are pleased to work with representatives from the Sponsor organizations to achieve this milestone," said Scott Shaunessy, CEO and Founder of ideaPoint. "Our solution is highly configurable and will allow the functionality to expand as the initiative matures over time".

As Researchers continue to search for treatments and cures to some of society's biggest medical challenges, the need to seek scientific insights that may lead to potential improvements in patient care has become a pressing issue. For the first time, Researchers can select studies of interest from multiple Sponsors across multiple disease areas and submit a single Research Proposal through a user-friendly portal. Research proposals to access data are reviewed by an Independent Review Panel (IRP) to ensure the proposed research makes a useful contribution to science. The site includes easy-to-follow videos and visual instructions on how to submit a proposal - all available at https://www.clinicalstudydatarequest.com/Step-By-Step.aspx.

In addition to Research Proposal requests for data already uploaded to the site, Researchers can also submit inquiries to study Sponsors to ask about the availability of data from studies not yet listed. The site includes a Data Sharing Agreement that requires all Researchers to post a summary of their research within one year of their analyses, and seek publication in a peer-reviewed journal.

The portal currently houses multiple studies available from the Sponsor organizations. It has been designed with a flexible configuration so that other industry, academic, and non-profit Sponsors can join and include their studies. Those interested should contact info@clinicalstudydatarequest.com for more information.

ideaPoint and the founding Sponsors believe this site launch is an important first step towards providing greater access to patient-level data in support of biomedical research, and look forward to continued and expanded collaboration within the research community as this initiative evolves over time.

About ideaPoint

ideaPoint, an Anaqua product, is an enterprise software that helps global Life Science companies accelerate quality decisions on innovation opportunities that have a material impact on their business.

Since its launch in 2008, ideaPoint has delivered software solutions to industry-leading Pharmaceutical, Biotechnology and Medical Device organizations to capture and assess opportunities for collaboration, licensing and acquisition, venture investing, and other partnering models that create growth through new products, new services and new business creation.

Media Contact:
Scott Martin
KMR Group
312.795.0400
Email: smartin@kmrgroup.com